Skip to main content
Clinical Trials/NCT05163431
NCT05163431
Completed
Not Applicable

Dimensional Validation of the Hallux Valgus Orthosis

TOPMED1 site in 1 country4 target enrollmentStarted: July 20, 2021Last updated:
ConditionsHallux Valgus

Overview

Phase
Not Applicable
Status
Completed
Sponsor
TOPMED
Enrollment
4
Locations
1
Primary Endpoint
Change in pain at 1 month

Overview

Brief Summary

The goal of this project is to optimize the design of the orthosis by establishing the key volumetric characteristics of the custom iterations in order to subsequently transpose them to a standard model and establish the increment proportions of the different sizes. The final product should reduce the pain by repositioning the phalanges of the first toe with the first metatarsal in its axis.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Painful hallux valgus
  • three people maximum per shoe size

Exclusion Criteria

  • People with diabetes ;
  • People with severe obesity ;
  • People with hallux rigidus;
  • People wearing full-time foot orthosis;
  • People wearing high heel shoes regularly ;
  • People with degenerative disease ;
  • People with neuromuscular pathology ;
  • People with a circulatory disorder ;
  • People who have had major lower body surgery;
  • People with epilepsy or with a history of epilepsy.

Outcomes

Primary Outcomes

Change in pain at 1 month

Time Frame: At baseline and 1 month

Pain is measured with a Likert scale from 1 (decrease of pain) to 5 (increase of pain).

Change in comfort at 1 month

Time Frame: At baseline and 1 month

Comfort is measured with a Likert scale from 1 (not comfortable) to 5 (very comfortable).

Change in big toe deviation angle during gait at 1 month

Time Frame: At baseline and 1 month

The big toe deviation angle is the angle between the big toe and the gait axis and measured with a motion capture system.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
TOPMED
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials